Related Experiment Video
Updated: Oct 17, 2025
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
6.0K
Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas
Laura Libera1, Giorgia Ottini1, Nora Sahnane1
1Unit of Pathology, Department of Medicine and Surgery, ASST Sette-Laghi, University of Insubria, 21100 Varese, Italy.
Cancers
|October 13, 2021
Summary
Genetic and epigenetic analysis of poorly differentiated sinonasal carcinomas (PDSNCs) revealed specific defects linked to LINE-1 hypermethylation. This epigenetic alteration is associated with a worse prognosis in these rare cancers.
Area of Science:
- Oncology
- Epigenetics
- Genomics
Background:
- Poorly differentiated sinonasal carcinomas (PDSNCs) are aggressive, rare malignancies.
- Molecularly distinct subtypes of PDSNCs are emerging, including those with SWI/SNF complex or IDH mutations.
- Epigenetic markers, particularly DNA methylation, may aid in classification and prognosis.
Purpose of the Study:
- To investigate the genetic and epigenetic landscape of PDSNCs.
- To identify correlations between specific genetic defects, DNA methylation patterns, and patient prognosis.
- To explore the potential of molecular characterization for tailored therapeutic strategies.
Main Methods:
- Histopathological and immunohistochemical review of 53 PDSNCs.
- Next-generation sequencing (NGS), Sanger sequencing, and MLPA for mutational profiling.
- LINE-1 bisulfite PCR and pyrosequencing for global DNA methylation analysis.
Main Results:
- Identified nine cases with SWI/SNF complex defects and five with IDH2 mutations.
- Found a significant correlation between INI-1/IDH2 defects and LINE-1 hypermethylation (p=0.002, p=0.032).
- Observed that LINE-1 hypermethylation was associated with a worse prognosis (p=0.007).
Conclusions:
- Genetic and epigenetic profiling of PDSNCs is crucial.
- Identification of distinct prognostic entities is possible through molecular characterization.
- Tailored clinical treatment strategies may benefit from this detailed characterization.
